Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University.

Saved in:
Bibliographic Details
Title: Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University.
Authors: Ferenczi K; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Nagy ZF; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Istenes I; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Eid H; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Bödör C; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Timár B; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Demeter J; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Source: Pathology oncology research : POR [Pathol Oncol Res] 2023 Nov 08; Vol. 29, pp. 1611378. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: eCollection Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-2807
DOI:10.3389/pore.2023.1611378